SCHEMBL6196640

SCHEMBL6196640

CCCCCN(NC(=O)NC)C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 4/20 0.36
KDM4C Q9H3R0 3/20 0.36
KDM5C P41229 1/20 0.36
KDM5B Q9UGL1 1/20 0.36
EPHX1 P07099 6/20 0.35
PHF8 Q9UPP1 3/20 0.35
AKR1B1 P15121 1/20 0.34
PPARG P37231 4/20 0.33
PPARD Q03181 4/20 0.33
PPARA Q07869 4/20 0.33
TSHR P16473 3/20 0.33
GPR84 Q9NQS5 3/20 0.33
HDAC11 Q96DB2 3/20 0.33
ALDH1A1 P00352 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
SLC22A6 Q4U2R8 1/20 0.33
SLC22A8 Q8TCC7 1/20 0.33
TLR2 O60603 1/20 0.33
S1PR2 O95136 1/20 0.33
S1PR1 P21453 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11650931 0.84 CA12 (0.39) KDM5AKDM4CEPHX1PHF8AKR1B1
SCHEMBL8648404 0.81 GPR84 (0.40) KDM5AKDM4CEPHX1PHF8PPARG
SCHEMBL22750272 0.81 KDM5A (0.38) KDM5AKDM4CKDM5CKDM5BPHF8
SCHEMBL30771785 0.79 DNM1 (0.40) KDM5AKDM4CPHF8PPARGPPARD
SCHEMBL7743897 0.76 CA12 (0.39) KDM5AKDM4CPHF8AKR1B1PPARG
SCHEMBL7818338 0.74 CA12 (0.40) KDM5AKDM4CPHF8AKR1B1PPARG
SCHEMBL3602153 0.73 CA12 (0.36) KDM5AKDM4CPHF8ALDH1A1MEN1
SCHEMBL4773599 0.70 KDM5A (0.36) KDM5AKDM4CKDM5CKDM5BPHF8
SCHEMBL7509889 0.69 KDM5A (0.38) KDM5AKDM4CKDM5CKDM5BEPHX1
SCHEMBL31478702 0.67 HPGD (0.59) TDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1494663-A1 DERIVATIVES OF 1-(OXOAMINOACETYL) PENTYLCARBAMATE AS CATHEPSIN K INHIBITORS FOR THE TREATMENT OF BONE LOSS SmithKline Beecham Corporation (US) 2005-01-12 EP disclosed
EP-1465862-A1 CYCLOALKYL KETOAMIDES DERIVATIVES USEFUL AS CATHEPSIN K INHIBITORS SmithKline Beecham Corporation (US) 2004-10-13 EP disclosed
WO-2003086385-A1 DERIVATIVES OF 1-(OXOAMINOACETYL) PENTYLCARBAMATE AS CATHEPSIN K INHIBITORS FOR THE TREATMENT OF BONE LOSS SMITHKLINE BEECHAM CORPORATION (US) 2003-10-23 WO disclosed
WO-2003062192-A1 CYCLOALKYL KETOAMIDES DERIVATIVES USEFUL AS CATHEPSIN K INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-07-31 WO disclosed